Stephen Pennington

Background

About Stephen Pennington

Steve is a chemist (Imperial College, London) and PhD biochemist (University of Cambridge) by training. He has spent much of his research career using mass spectrometry to measure and characterise proteins. Steve has given over 300 invited presentations at international events, published over 150 scientific papers as well as editing and contributing to several books including editing one of the first books on Proteomics that was translated into Chinese and Japanese. He is on the editorial board of several journals including in a more senior capacity for 'ClinicalnProteomics' and the 'Journal of Proteomics' and regularly reviews manuscripts and grants for a number of international organisations. Steve is a past committee member of European Proteomics Association and British Society for Proteome Research. He was the lead organiser of 16th Human Proteome Organisation (HUPO) World Congress held in the national Convention Centre in Dublin from 17-20th Sep 2017. Steve is focused on bringing protein biomarker research endeavours to clinical utility and value. His research group’s interests and activities are joined by a common theme of measurement of protein expression and function on a comprehensive proteomics scale. Current projects are focussed on the mass spectrometry based discovery, measurement and validation of protein biomarkers to take them from discovery to clinical utility, predominantly in oncology and inflammatory disease. Steve’s team are also investigating the mechanisms of disease progression focussing on prostate cancer and psoriatic arthritis. Steve has founded a UCD spinout company Atturos to develop blood-based biomarker tests that help clinicians make better treatment decisions for patients.